Development of RNA Base Editing Technologies for Precision Medicines with Axiomer® and Trident® presented at TIDES USA 2022 by Gerard Platenburg - ProQR Therapeutics.
This is Gerard Platenburg's presentation at the 5th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2024) in San Diego, California.
… machinery. Axiomer® RNA editing technology harnesses ADAR(Adenosine Deaminase Acting on RNA), which is machinery … To take care of laboratory organization and related administrative tasks Competencies that are required for …
… machinery. Axiomer® RNA editing technology harnesses ADAR(Adenosine Deaminase Acting on RNA), which is machinery … To take care of laboratory organization and related administrative tasks To have a proven ability to effectively …
… machinery. Axiomer® RNA editing technology harnesses ADAR(Adenosine Deaminase Acting on RNA), which is machinery … with wet-lab scientists, technicians, project leads. Skills and competencies that are required for making …
… machinery. Axiomer® RNA editing technology harnesses ADAR(Adenosine Deaminase Acting on RNA), which is machinery … designing and implementing a new product planning process Leads new product planning, positioning, and pre-launch …
… machinery. Axiomer® RNA editing technology harnesses ADAR(Adenosine Deaminase Acting on RNA), which is machinery … Director (Full-time) to join us for a 9-12 month period to lead the Regulatory Affairs activities to cover maternity …
… machinery. Axiomer® RNA editing technology harnesses ADAR(Adenosine Deaminase Acting on RNA), which is machinery … Leiden, NL (on-site) The Senior Clinical Scientist will lead the scientific and operational elements of the Clinical …